Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: Patient and treatment-related risk factors

British Journal of Cancer

Volumn 110, Issue 1, 2014, Pages 49-54

  Zeng, L ^a,b   Tian, Y M ^a,b   Sun, X M ^a,b   Chen, C Y ^a,b   Han, F ^a,b   Xiao, W W ^a,b   Deng, X W ^a,b   Lu, T X ^a,b  

^a Department of Colorectal Surgery   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

chemotherapy; intensity modulated radiotherapy; late toxicity; nasopharyngeal carcinoma; temporal lobe injury

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CRANIAL NERVE PARALYSIS; CRANIAL NEUROPATHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; DYSPHAGIA; EYE INJURY; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; HYPOPITUITARISM; HYPOTHYROIDISM; INTENSITY MODULATED RADIATION THERAPY; LHERMITTE DUCLOS DISEASE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OTORRHEA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RISK FACTOR; SECOND CANCER; SURVIVAL RATE; TEMPORAL LOBE; TEMPORAL LOBE LESION; TINNITUS; TREATMENT FAILURE; TRISMUS; XEROSTOMIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHINA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84891867435     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.720     Document Type: Article

References (25)

1. Butler EB, Teh BS, Grant WH, Uhl BM, Kuppersmith RB, Chiu JK, Donovan DT, Woo SY (1999) Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45: 21-32. (Pubitemid 29380070)
2. Chao KS, Jo Deasy, Markman J, Haynie J, Perez CA, Purdy JA, Low DA (2001) A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49: 907-916. (Pubitemid 32184597)
3. Chau RM, Teo PML, Choi PH, Cheung KY, Lee WY (2001) Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol 58: 143-153. (Pubitemid 32146516)
4. Chen HH, Tsai ST, Wang MS, Wu YH, Hsueh WT, Yang MW, Yeh IC, Lin JC (2006) Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66: 1408-1414.
5. Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T (2009) Effect of cisplatin on parotid gland function in concomitant radiochemotherapy. Int J Radiat Oncol Biol Phys 75: 1475-1480.
6. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76: S20-S27.
7. Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, Lee MC, Bentzen SM (2009) Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors. Int J Radiat Oncol Biol Phys 73: 1121-1128.
8. Lee AW, Sze WM, Au JSK, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL, Lau WH (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107-1116. (Pubitemid 40340904)
9. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53: 12-22. (Pubitemid 34465802)
10. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C, Ang KK (2009) Intensitymodulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 27: 3684-3690.
11. Leung TW, Tung SY, Sze WK, Wong FC, Yuen KK, Lui CM, Lo SH, Ng TY, O SK (2005) Treatment results of 1070 patients with nasopharyngeal carcinoma: An analysis of survival and failure patterns. Head Neck 27: 555-565. (Pubitemid 40961062)
12. Leung TW, Wong VYW, Sze WK, Lui CM, Tung SY (2008) High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 70: 361-367.
13. Miah AB, Gulliford SL, Bhide SA, Zaidi SH, Newbold KL, Harrington KJ, Nutting CM (2013) The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT. Radiother Oncol 106: 346-351.
14. Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS, Lee AW (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 79: 420-428.
15. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66: 981-991. (Pubitemid 44633504)
16. Radiation Therapy Oncology Group (2008) Radiation Therapy Oncology Group Protocol 0225 http://www.rtog.org/members/protocols/0225/0225.pdf. Accessed: 26 August 2008.
17. Su SF, Han F, Zhao C, Chen CY, Xiao WW, Li JX, Lu TX (2012a) Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys 82: 327-333.
18. Su SF, Huang Y, Xiao WW, Huang SM, Han F, Xie CM, Lu TX (2012b) Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma. Radiother Oncol 104: 312-316.
19. Teo ML, Ma BY, Chan ATC (2004) Radiotherapy for nasopharyngeal carcinoma-transition from two-dimensional to three-dimensional methods. Radiother Oncol 73: 163-172. (Pubitemid 39470155)
20. Tham IW, Hee SW, Yeo RM, Salleh PB, Lee J, Tan TW, Fong KW, Chua ET, Wee JT (2009) Treatment of nasopharyngeal carcinoma using intensitymodulated radiotherapy-The National Cancer Centre Singapore experience. Int J Radiat Oncol Biol Phys 75: 1481-1486.
21. Tian Y, Gou R, Zhu MF (2002) Radiation encephalopathy in nasopharyngeal carcinoma patients in mainland China: a systematic evaluation. Chin J Oncol 24: 471-473.
22. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64: 57-62. (Pubitemid 41831209)
23. Wong FC, Ng AW, Lee VH, Lui CM, Yuen KK, Sze WK, Leung TW, Tung SY (2010) Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 76: 138-145.
24. Xiao WW, Huang SM, Han F, Wu SX, Lu LX, Lin CG, Deng XW, Lu TX, Cui NJ, Zhao C (2011) Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 117: 1874-1883.
25. Zhao C, Lu TX, Han F, Lu LX, Huang SM, Deng XW, Lin CG, Cui NJ (2006) Clinical study of 139 nasopharyngeal carcinoma patients for intensity modulated radiation therapy. Chin J Radiat Oncol 15: 1-6.